The list is arranged by deadline chronological order. Israeli calls first, then foreign calls.
For assistance please contact Research Promotion Unit (RPU): ra-tec@technion.ac.il
Robi
Iris
Luba
-
Normal viewExtended view
-
Filter by:
Israeli
Era-Net (MOH): EP ERA4Health– “Prevent-OO: Understanding and Preventing Overweight and Obesity”
Mechanisms of their onset and progression, neglected determinants and novel strategies for critical transitional periods in life
Pre announcement
The call will be implemented in two stages, a pre- and a full-proposal phase.
This call will support transnational collaboration of multidisciplinary scientists from different countries to work together across borders, taking advantage of complementary expertise and sets of data. The call will finance research that improves the understanding of the causes for obesity, overweight and its complications by using a mechanistic approach, as well as studies aiming at the development of public health strategies for the prevention of obesity and overweight by focusing on critical transitional periods of life, which are due to either biological or socio-environmental changes
Information day 18 November 2025h
* A short abstract and budget should be sent to the ministry of Health (MOH) prior to pre-proposal submission. Call us for clarifications and MOH abstract forms (tel. 2152, 1272, 1477).
Era-Net (MOH): THCS (Transforming Health and Care Systems) – Access to Care (Pre-proposals)
The call will be implemented in two stages, a pre- and a full-proposal phase.
Aim: to fund projects that contribute to ensuring equitable access to and utilisation of health and care services. Through the funded research and innovation projects, policy and decision makers should gain the knowledge and tools necessary to implement the reallocation of resources as the health and care system undergoes a transition to meet new and ongoing challenges.
Projects funded under this call will build on existing evidence to deliver innovative solutions that enable key stakeholders to reduce inequalities in access to and utilisation of health and care services. Projects will address how to improve access to all levels of health and care through financial models, models for delivering health and care services and setting up of interdisciplinary integrated care programmes.
Information webinar 10 December 2025, 14:00-16:00 CET
* A short abstract and budget should be sent to the ministry of Health (MOH) prior to pre-proposal submission. Call us for clarifications and MOH abstract forms (tel. 2152, 1272, 1477).
https://www.thcspartnership.eu/funding/jtc-2026-access-to-care.kl
Era-Net (MOH): EUP OHAMR joint transnational call “Treatments and Adherence to Treatment protocols” – Pre announcement
The aim of this first EUP OHAMR Call is to improve the treatment success rates of the patients, animals and plants affected by bacterial or fungal infections by providing new treatment options while reducing the risk of resistance in the different One Health settings.
Call topics:
– Identify and develop new combination treatments using existing or innovative antimicrobials or antimicrobial with adjunctive treatments to extend drug efficacy and combat resistance.
– Develop tools and methods to improve adherence to treatment protocols.
– Assess the impact of antimicrobials for veterinary and agricultural use on the risk of AMR transmission to humans and the environment to inform policies on the restriction of some antimicrobials for human use.
* The consortium must include a minimum of three (3) eligible partners asking for funding from three (3) different eligible countries (including at least two amongst EU Member States or Associated Countries).
Funding: up to 140K EUR (additional 40K EUR for Israeli coordinators)
https://ohamr.eu/
https://ohamr.eu/funding/funding-opportunities/call-2025-new-treatments-to-tackle-amr/
* A short abstract and budget should be sent to the ministry of Health (MOH) prior to pre-proposal submission. Call us for clarifications and MOH abstract forms (tel. 2152, 1272, 1477).
An information webinar for potential applicants will take place on 26 November, 14:00–15:30 (Stockholm):
For registration: https://sv-se.eu.invajo.com/event/eupohamr/webinarforapplicants
Era-Net (MOH): ERDERA translational call for “Resolving unsolved cases in rare genetic and non genetic diseases through variant validation and new technological approaches” – Pre announcement
The call will be implemented in two stages, a pre- and a full-proposal phase.
The call will welcome proposals focused on providing diagnostic clarity in unsolved rare genetic and non‑genetic diseases. Involving patient organizations from the very start is highly desirable.
Funding: up to 140K EUR (additional 40K EUR for Israeli coordinators)
https://erdera.org/call/joint-transnational-call-2026/
* A short abstract and budget should be sent to the ministry of Health (MOH) prior to pre-proposal submission. Call us for clarifications and MOH abstract forms (tel. 2152, 1272, 1477).
An information webinar for potential applicants will take place on 16 December, 15:00–17:00 CET:
For registration: https://erdera.org/event/information-webinar-erdera-joint-transnational-call-2026/
UC Davis: California-Israel Collaborations in Research Program
For joint research projects in the sciences, including: mathematical and physical sciences, biological sciences, engineering, agriculture,
and medicine, as specified in Award Details below. Proposals are invited that strengthen research collaboration through joint scientific publications, increased visibility and research impact, and co-application for extramural funding. Preference will be given to proposals creating new collaborations between researchers in California and Israel that are likely to result in long term projects.
The program includes three award types:
Full project: research funding of up to $10,000 per year for a total of up to $20,000 over the course of the project
Full project with undergraduate research supplement: research funding of up to $10,000 per year for a total of up to $20,000 over the
course of the project AND up to $5,000 to support an undergraduate researcher at UC Davis.
Mobility: one-time funding of up to $5,000 to cover research related travel expenses specifically intended for the exchange of knowledge or collaboration.
* Matching funds for full projects from Departments and Colleges are encouraged, but are not
factored into the award decision.
https://ucdavis.infoready4.com/#freeformCompetitionDetail/2001325
British Council, British Embassy in Israel and Pears Foundation: BIRAX Healthy Ageing | Call for Research Proposals – Preliminary Proposal
Research proposals to be submitted jointly by British and Israeli scientists that seek to further the understanding of ageing and its impact on human health and well-being. Welcome projects that use a holistic approach to healthy ageing, including pioneering techniques, state-of-the-art technologies and interdisciplinary approaches, showcasing the added value of international collaboration.
Funding: up to £400K for 3 years
BIRAX Healthy Ageing Sub-call for Follow-on Funding
This opportunity is open exclusively to previous project leads and co-leads of BIRAX-funded projects, enabling them to build on their successful research under the BIRAX Program (Regenerative Medicine Initiative and Healthy Ageing).
https://www.britishcouncil.org.il/en/birax/call-for-proposals
The Alrov Institute for Real Estate Research at Tel Aviv University: Call for Research Proposals
Seeks to advance state-of-the-art research in the broad area of real estate and urban economics.
Proposals for research papers on housing markets, commercial real estate markets, mortgage markets, real estate development, real estate entrepreneurship and investment, real estate capital markets, urban and regional economics, and any other topic related to the broad area of real estate and urban economics.
Funding: up to 30K NIS for up to 18 months (preferably up to 12 months).
https://www.alrov.sites.tau.ac.il/hebrew-content/call-for-research-proposals2025
Niedersachsen-Israel Research Cooperation – Natural Sciences, Mathematics and Engineering Sciences
Collaborative research projects with Niedersachsen (Lower Saxony, Germany) region (including Hannover, Göttingen, Braunschweig, Osnabrück, Oldenburg…). The objective of this program is to promote outstanding scientific high-risk – high-gain cooperation projects.
Funding: up to €500K for up to 4 years (no overhead).
https://zukunft.niedersachsen.de/en/funding-offers/research-cooperation-lower-saxony-israel/
FAQ: https://zukunft.niedersachsen.de/wp-content/uploads/2025/02/FAQ-Lower_Saxony-Israel.pdf
Human Frontier Science Program (HFSP): Research Grants in Basic Biology – Competitive LOI
*Please contact the Research Authority if planning to submit.
**Registration and obtaining reference number 18.3, LOI due 27.3
HFSP supports international collaborations in fundamental Life Sciences research with emphasis on innovative and interdisciplinary approaches to understanding complex mechanisms of living organisms. Preliminary results are not required.
Research Grants – Program: to teams of independent researchers at any stage of their careers. The research team is expected to develop new lines of research through the collaboration. Applications including independent investigators early in their careers are encouraged.
Early Career: all members must be within 5 years of obtaining an independent position and must have obtained their first doctoral degree (PhD, MD or equivalent) no longer than 10 years before the deadline for submission of the Letter of Intent. They must be in a position to initiate and direct their own independent lines of research.
Funding: Grants provide 3 years support.
Awards are dependent upon team size (for instance 2-member teams will receive 300 000 USD and 4-member teams 500 000 USD per year.
The principal applicant must be located in one of the member countries [Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Cyprus (EU part), the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, India, the Republic of Ireland, Israel, Italy, Japan, the Republic of Korea, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, New Zealand, Poland, Portugal, Romania, Singapore, Slovakia, Slovenia, Spain, Sweden, Switzerland, the United Kingdom, and the United States of America..]. Co-investigators may be in any country, with at least one in a country other than the PA. The number of team members should normally be 2 – 4.
Dahlia Greidinger Foundation: Young researchers in the Cancer Research
קרן דליה גרידינגר ז”ל למלחמה בסרטן: קול קורא לתמיכה בחוקרים צעירים בתחום הסרטן
הקרן תומכת בחוקרים צעירים, עד גיל 45, למחקר בתחום הסרטן. מימון: 100,000 ש”ח לשנתיים.
NSF-BSF programs
Israeli researchers can join research proposals submitted by US PI(s) to the NSF, in the programs listed below. Two applications per calendar year (Oct 1 – Sept 30) are permitted.
The Israeli budget is funded by the BSF as follows: up to $114K/yr for experimental studies and $94K/yr for theoretical and computer-based studies.
* If more than one lab will be involved in the research they will able to request up to 150% of the budget. These sums are subject to the availability of funds.
Pay attention to the application deadlines. While many programs are open all year long, some still have specific time limits.
Details on all NSF-BSF programs: www.bsf.org.il/funding-opportunities/nsf-bsf-joint-research-grants/the-programs/
· Behavioral and Cognitive Sciences – Various Dates
· Economics and Decision Sciences – Aug 18, 2025
· Sociology – Open All Year
· Molecular and Cellular Biosciences (MCB) – Open All Year
· Integrative and Organismal Systems (IOS) – Open All Year
· Environmental Biology (DEB-Core) – Open All Year
· Computational Neuroscience (CRCNS) – 12 Nov, 2025
· Biological Infrastructure (DBI) – Open All Year
· Cyber Security and Privacy – Open All Year – In any case, Israeli PIs will consult with
Ms. Yael Dressler in the BSF office (yael@bsf.org.il) regarding their project description
and budget request before advancing the preparation and submission of their proposal.
· Foundational Research in Robotics – Open All Year
· Computational and Data-enabled Science and Engineering (CDS&E) – Open All Year
· Computer and Information Sciences and Engineering (CISE) – Open All Year,
proposers are strongly encouraged to submit by the target dates – 11 Sep 2025, 5 Feb 2026.
· Computing and Communication Foundations (CCF) – Open All Year
· Computer Networks and Systems (CNS) – Open All Year
· Information and Intelligence Systems (IIS) – Open All Year
· Chemistry (CHE) – Various Dates
· Physics – Various Dates
· Materials (DMR) – Open All Year
· Astronomy and Astrophysics – Nov 17, 2025
· Mathematics – Various Dates
· Mathematical and Scientific Foundations of Deep Learning – Various Dates
· Electrical, Communications and Cyber Systems (ECCS) – Open All Year
· Chemical, Bioengineering, Environmental and Transport Systems (CBET) – Open All Year
· Civil, Mechanical and Manufacturing Innovation (CMMI) – Open All Year
· Earth Sciences (GEO) – Open All Year
· Atmospheric and Geospace Sci. – Open All Year
· Marine Oceanography – Open All Year
· EAGER (Early-Concept Grants for Exploratory Research) – Open All Year
· Smart Health and Biomedical Research (SCH) – 3 Oct, 2025
NEH-BSF programs: Collaborative Initiative to Enhance Research in the Humanities
Award is up to $25,000 or Convening up to $50,000. For programs in which the maximum award amount allowed by the NEH is less than $50,000 per year, the request to the BSF cannot exceed the maximum award amount per year.
https://www.bsf.org.il/funding-opportunities/neh-bsf-research-grants/about/
This partnership provides a unique opportunity for joint research projects between U.S. and Israeli scholars across several NEH programs, including:
Dangers and Opportunities of Technology: Sep 04, 2025
Research and Development: May 20, 2025
Archaeological and Ethnographic Field Research: Sep 24, 2025
Collaborative Research November 19, 2025
ICL (Israeli Chemicals Ltd): ICL Open Innovation (Crop Nutrition and Applied Agronomy)
ICL is looking to fund research projects in the following domains:
Crop Nutrition:
- Enhanced Efficiency Fertilizers
- Biostimulants
- Biodegradable CRF Coating
- Nitrogen Fixation
- Organic Fertilizers
- Secondary nutrients
- Delivery Platform
- Ammonia synthesis
- Increased P-availability
Applied Agronomy
- Efficient fertilizers application
- Regenerative Agriculture practical methods
- Water use efficiency practical methods
- Nutrient balance (plant, soil, water, atmosphere) sensing/analysis
- GHG emissions sensing/analysis
- Soil microbiome sensing/analysis
- Soil/groundwater contamination sensing/analysis
- Yield estimation by remote sensing
- Plant nutrition’s DSS
Funding: The budget for the selected proposals will be negotiated with ICL
For further details, please contact Adi Perelman Adi.Perelman@icl-group.com
Foreign
ChadTough Defeat DIPG Foundation: Research Grants in Diffuse Intrinsic Pontine Glioma (DIPG) – LOI
* New Investigator Grant: Supporting newly independent DIPG researchers working to establish DIPG research labs – OR – established researchers (who have not previously conducted DIPG/DMG research) to encourage them to start. Funding: up to $400K over 3 years.
* Game Changer Grant: Hypothesis-driven research projects that represent an innovative approach to a major challenge in DIPG research, with a potential to lead to groundbreaking discoveries in the field. Funding: up to $600K over 3 years.
www.chadtough.org/research/grant-application
Parkinson’s UK: Drug Accelerator Awards – preproposals
These awards will help pioneer and accelerate novel drug development for the treatment of Parkinson’s, providing researchers the opportunity to generate the essential data and help bridge the gaps needed to get their projects/compounds ready to enter full scale drug discovery with an industry partner or the Parkinson’s Virtual Biotech.
Looking for projects that will have a clear focus on translational drug development to make a difference to those affected by Parkinson’s.
Funding: There is no minimum award amount and the maximum award amount is £150,000.
For projects involving in vivo work, an award amount of up to £200,000 will be considered.
Lead PI must be UK based
https://www.parkinsons.org.uk/research/drug-accelerator-awards
Thrasher Research Fund: E.W. “Al” Awards in Pediatrics – Concept Paper
The purpose of the Fund is to provide grants for clinical, hypothesis-driven research that offers substantial promise for meaningful advances in the prevention, diagnosis and treatment of children’s diseases, particularly research that offers broad-based applications.
Funding: up to $600K for 3 years (7% overhead).
https://www.thrasherresearch.org/al-thrasher-award?lang=eng
Hereditary Disease Foundation: Transformative Research Award in Huntington’s disease – competitive LOI’s
To advance transformational collaborative projects to provide new insights into disease mechanisms or create or implement tools and technologies not previously applied to Huntington’s disease research for the advancement of therapeutics. General areas include but are not limited to: whether modulation of somatic repeat instability is disease modifying, whether and how cellular, biochemical or molecular insights in HD systems are predictive of disease, or how to apply unexplored therapeutics for clinical application (inclusive of biomarkers). Projects that discover disease modifying targets and incorporate novel tools or technologies are encouraged. Projects must justify how results could ultimately connect to therapies.
Funding: $300K-$500K per year for up to a two-year period.
https://hdfoundation.org/apply/
Nature Awards: Eppendorf Award for Young European Investigators
Granted annually to one early career scientist in Europe not older than 35 years at the time of entry. It acknowledges outstanding contributions to biomedical research in Europe based on methods of molecular biology, including novel analytical concepts.
Funding: 20,000 Euro (for personal use)
https://www.nature.com/nature/awards/eppendorf
Huntington’s Disease Foundation: Transformative Research Award – Competitive LOI’s
To advance transformational collaborative projects that will provide new insights into disease mechanisms or create or implement tools and technologies not previously applied to Huntington’s disease (HD) research for the advancement of therapeutics. Partnerships between academia and industry and those bringing scientific expertise from outside the HD field are strongly encouraged.
Funding: $300K-$500K per award per year for up to 2 years.
Bill & Melinda Gates Foundation: Grand Challenges (LOI)
Metagenomic Next Generation Sequencing to Detect, Identify and Characterize Pathogens
Through this Grand Challenge, funding will be offered to 10 scientific groups to explore the identification, characterisation and context of infectious disease in low and middle-income country (LMIC) settings. Selected applicants will benefit from onsite next generation sequencing and rapid pathogen detection to better understand their local pathogen landscape.
Funding: up to $200,000 over 2 years.
Rosetrees: Major Project Awards in translational Medical Research – LOI
* Allow collaborations with Israeli PI’s – The main PI must be UK based.
Supporting cutting edge medical research with focus on testing new ideas across the spectrum of medical research to bring the earliest patient benefit.
Major project grants support innovative research projects with an established proof-of-concept. It is expected that our funding will enable projects to develop further towards clinical translation and should target an unmet clinical need impacting a significant patient population in the UK. Proposals focusing on rare diseases will also be considered if applicants can demonstrate that their research has potential applications to a broader range of clinical conditions.
Due to our upcoming Dementia Teams Award funding call in partnership with Race Against Dementia, we will not be accepting dementia-related projects in this major project grant round. However, projects exploring dementia and quality of life remain eligible, as these topics fall outside the Race Against Dementia partnership.
Funding: up to £210,000 over 3 years.
https://rosetrees.org.uk/project_awards
Advanced Research + Invention Agency (ARIA): Enduring Atmospheric Platforms – Concept papers
Please note: an applicant can submit a full proposal by April 2nd, without submitting a concept paper, yet on
average, 64% of applicants awarded funding submitted concept papers.
This program addresses the challenge of achieving ubiquitous, resilient connectivity by establishing a regionally scalable, high-performance alternative to orbital systems. Success enables low-cost, direct-to-device communications that current Low
Earth Orbit (LEO) satellite constellations struggle to support practically, creating a UK-led,
sovereign capability in advanced communications infrastructure.
Applications invited from interdisciplinary teams that bridge fields such as aerospace engineering, advanced materials, energy generation, energy storage, and autonomy.
Funding: overall budget of £5M, individual projects are expected to receive multi-million-pound awards—often in the range of £1–5 million per project, depending on complexity and deliverables for max 3.5 years.
* Primary focus is on funding those who are based in the UK. However, funding will be awarded to organizations outside the UK if we believe it can boost the net impact of a program in the UK. In these instances, one must outline your proposed plans or commitments that will contribute to the program in the UK within the project’s duration
https://www.aria.org.uk/opportunity-spaces/scoping-our-planet/enduring-atmospheric-platforms/
Enduring Atmospheric Platforms Program FAQ + Lightning Talk webinar will be held on Dec 15, 2025 04:00 PM, for registration: https://eu01web.zoom.us/webinar/register/WN_DpbO-cBrRSuJ8rrvSPdIZw#/registration
National Multiple Sclerosis Society: Research Grants (Pre-application)
Funding for investigator-initiated proposals to support research focused on addressing research questions highlighted in the Pathways to MS Cures Roadmap
Funding: up to $200K per year (including indirect costs) for up to 3 years
Breakthrough T1D (formerly JDRF): Translational Strategies to Define, Enhance, and Monitor Vascularization for Durable Islet Replacement Therapies – Competitive LOI’s
To support translational research that advances the clinical application of vascularization- and engraftment-focused strategies for islet replacement therapy in type 1 diabetes (T1D).
Funding: up to $900K over 3 years
https://www.breakthrought1d.org/wp-content/uploads/2025/12/RFA_Vascularization_Call-Document.pdf
https://www.breakthrought1d.org/explore-research/funding-opportunities/
Breakthrough T1D (formerly JDRF): In vitro Disease Modeling: Type I Diabetes-on-a-Chip Platforms for Translational Research – Competitive LOI’s
A new funding opportunity to support advancement of cutting-edge organoid- and organ on a chip-based disease models of Type I Diabetes (T1D).
This initiative aims to validate and refine existing human-relevant in vitro models of T1D as tools for evaluation of pharmacological and genetic interventions with the goal of accelerating translation to clinical studies.
Funding: up to $300K over one year
https://www.breakthrought1d.org/wp-content/uploads/2025/12/RFA_Organ-on-a-chip_Call-Document.pdf
https://www.breakthrought1d.org/explore-research/funding-opportunities/
Foundation Fighting Blindness: Career Development Award (CDA)
CDA’s goal is to help advance junior clinical research scientists in their professional endeavors to cure retinal degenerative disease by: (1) facilitating advances in laboratory and clinical research; (2) elucidating the mechanism for the cause and pathogenesis of retinal degenerative diseases; (3) developing innovative strategies to prevent, treat and cure these diseases. This program supports up to 5 junior-level faculty, for 5 years at $75K/year. Clinician-scientists who are in their first, second, or third year of a junior faculty appointment, and are committed to solving the mysteries of inherited retinal diseases are encouraged to apply for a CDA. Individuals from underrepresented racial, ethnic and gender groups, as well as individuals with disabilities, are always encouraged to apply.
Novo Nordisk Foundation: Tandem Programme – Translational research collaboration between Basic and Clinical Researchers
* The project must be anchored at a university, hospital or other non-profit research institution in Denmark. The co-applicant can be anchored in Denmark or abroad.
One basic scientist and one clinical scientist must apply together for a project, which is clinically relevant, cross-disciplinary, and translational in nature, to catalyze improved treatment or diagnosis of patients, or understanding of underlying disease mechanisms.
Funding: DKK 11M-DKK 13M ($1.7M-$2M) for 4 years.
https://novonordiskfonden.dk/en/grant/tandem-programme-translational-research-collaboration-between-basic-and-clinical-researchers/
Sanofi Regeneron: Global Innovation Grant – Pathways in Type 2 Inflammation
(other deadlines by 30.5 and 30.9)
Research in type 2 inflammation and associated diseases, including, but not limited to, atopic dermatitis, bullous pemphigoid, chronic spontaneous urticaria, prurigo nodularis, eosinophilic esophagitis, asthma, chronic obstructive pulmonary disease, chronic rhinosinusitis with nasal polyps or other type 2 immune-mediated diseases that are relevant in clinical practice. We will prioritize research projects with clear potential to significantly advance scientific understanding of type 2 immune-mediated diseases and improve outcomes in patient care or reduce individual disease burden.
Funding: up to $500K
National Psoriasis Foundation
Discovery Grants: Support researchers while they explore preliminary ideas and conduct proof-of-concept experiments.
Funding: up to $75 per 1 year (No Overhead)
Early Career Research Grants: Support graduate students and postdoctoral researchers training to conduct psoriatic disease research independently.
Funding: up to $50 per 1 year (No Overhead)
Translational Research Grants: Support projects that advance basic science discoveries and studies into treatments that can benefit patients with psoriatic disease.
Funding: up to $100 per 1 year (No Overhead)
www.psoriasis.org/available-funding-opportunities
Eni Awards: Eni for Innovation
To promote and to award technological and digital innovation, developed at Eni, an essential lever to create value, transforming our business and the energy market of the future.
https://www.eni.com/en-IT/strategic-vision/innovation/eni-award.html
NATO: Science for Peace and Security (SPS)
Collaborative projects with NATO† countries addressing key priorities: Environment, Climate Change and Security/ energy security / Innovation and Emerging Disruptive Technologies (EDTs)/ Counter-terrorism /Chemical, Biological, Radiological, and Nuclear (CBRN) and Explosive Hazards Management/ Defence against Hybrid Threats / Resilience/ Critical Underwater Infrastructure/ Cyber Defence/ Assessing and addressing threats posed by the Russian Federation/ Strategic Foresight/ Human and Social Aspects of Security/ Operational Support/Any other proposal clearly linked to the implementation of NATO’s core tasks.
Grant Mechanisms:
Multi-year research & development projects of 2-3 yrs. three-year projects are in the €250K–€400K range.
Advanced Research Workshop: 2-5 day workshop averaging €30,000-€40,000.
Advanced Study Institutes (ASI): 7-10 days averaging €60,000
Advanced Training Course: 5-7 day course averaging €60,000.
No overhead.
†NATO countries: Albania, Belgium, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Iceland, Italy, Latvia, Lithuania, Luxembourg, Montenegro, Netherlands, the Republic of North Macedonia, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Turkey, United Kingdom, United States.
https://www.nato.int/en/about-us/organization/nato-structure/science-for-peace-and-security-hub/managing-sps-grants
https://www.nato.int/en/about-us/organization/nato-structure/science-for-peace-and-security-hub/sps-call-for-proposals-2026-1
Children’s Tumor Foundation: Drug Discovery Initiative (DDI)
Drug Discovery Initiative (DDI)
to stimulate NF drug discovery by funding researchers proposing to investigate novel or repurposing therapies for NF or to validate new NF targets. Proposals are expected to be short and concentrated on obtaining key preliminary data needed to quickly advance to the next step of drug discovery.
Funding: $200K for 2 years
www.ctf.org/funding-opportunities
Jacobs Foundation: CIFAR Research Fellowship Program
Offers fellowships to early- and mid-career researchers whose work is dedicated to improving the learning and development of children and youth worldwide.
The relevant disciplines include, but are not limited to, education sciences, psychology, economics, sociology, behavioral science, computer science, pedagogy, linguistics, neurosciences, and science of learning.
* Fellowships are awarded to talented researchers who have received their PhDs within the past 10 years.
Funding: CHF 165K (~$207K, including 10% Overhead)
https://jacobsfoundation.org/activity/jacobs-foundation-research-fellowship-program/
Children’s Tumor Foundation: Clinical Research Award (CRA)
Clinical Research Award (CRA)
Aims to advance the development of effective clinical treatments, interventions, and management of patients living with NF.
Funding: $200K for 2 years
www.ctf.org/funding-opportunities
Leukemia Research Foundation – LOI
New investigator research projects that will have an impact on leukemia.
Funding: $150K for 2 years.
The Liveability Challenge 2025: Decarbonisation and Cool Earth
Decarbonisation
We are looking for disruptive deep-tech solutions that provide scalable and impactful solutions to reduce carbon emissions across diverse industries, as: waste-to-resource, renewable energy, and energy efficiency.
Cool Earth
We are seeking groundbreaking innovations that specifically address the challenges posed by climate-induced extreme weather conditions, as:heat mitigation, nature-based solutions.
Funding: $1M prize for each track
https://www.theliveabilitychallenge.org/
Friedreich’s Ataxia Research Alliance (FARA) – LOIs
Supports research across the spectrum from basic research through drug development and clinical research programs in Friedreich’s Ataxia (FA).
Funding: $125K for 1-2 years
FARA is willing to consider ad-hoc proposals of cycle that are high-value projects. For more information, please contact FARA at grants@curefa.org
Keith Michael Andrus Cardiac Award proposals for this award should focus on advancing understanding and/or treatment of the cardiac involvement in FA.
$125,000 per year for 1 or 2 years
Kyle Bryant Translational Research Award Eligible applications should focus on accelerating completion of translational stage activities necessary for advancement to clinical study of a therapeutic candidate or development of novel tools that address a critical bottleneck to the discovery or development of therapies.
$200,000 per year for 1 or 2 years
Bronya J. Keats Research Collaboration Award . Proposals should focus on FA research that relies on collaboration among investigators from at least two different institutions. Special consideration will be given to proposals that involve international collaborations and bring new scientists to the FA community. The rationale for the collaboration needs to be convincing: it must clearly demonstrate that the research goals could not be achieved by just one of the participating groups and the synergy among the groups is essential for the success of the project.
$175,000 per year for 1 or 2 years
The Michael J. Fox foundation: Parkinson’s Disease Therapeutics Pipeline Program
Applicants may submit a pre-proposal application at any time. Pre-proposals will be reviewed by MJFF within three weeks of submission. Applicants whose pre-proposal is selected for further consideration will be invited to submit a full proposal through one of the four review cycles.
This program seeks to advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease (PD). The program is set up to benefit therapeutics with clear potential to prevent, stop, or delay disease progression or to reduce the burden of daily symptoms.
The Therapeutics Pipeline Program is only open to industry and industry-academia collaborations.
Funding: Award amounts for this program may range from $250,000 for smaller, targeted programs to upwards of $2M for larger, multi-stage preclinical and/or clinical programs
Duration: 1-2 years for pre-clinical programs, 2-3 years for clinical programs
Spencer Foundation: Education Research Large Grants – LOI
Supports education research projects that will contribute to the improvement of education, broadly conceived. Aims at rigorous, intellectually ambitious and technically sound research that is relevant to the most pressing questions and compelling opportunities in education.
Funding: up to $500,000 over 1-5 years (Non-profit)
https://www.spencer.org/grant_types/large-research-grant
The Autism Science Foundation (ASF): Profound Autism Research Grants
Focused on profound autism and severe, intense, and dangerous behaviors. Priority will be given to projects that identify biological mechanisms, evaluate treatments or interventions, or address barriers to conducting research with individuals who have profound autism.
Funding: up to $35K for 1 year (No Overhead)
https://autismsciencefoundation.org/apply-for-a-profound-autism-pilot-grant/
* A virtual Q&A session will be held on Monday, December 22, 2025, at 1:00 PM ET: https://us06web.zoom.us/meeting/register/fPqvJ5MCTAWQ89pMJ9_fYw#/registration
Novo Nordisk Foundation: Data Science Collaborative Research Programme 2026
* The main applicant must be associated to/employed at a university or institution in Denmark during the project period. The co-applicant(s) can be anchored in Denmark or abroad.
Aims to support synergistic research collaborations rooted in data science and computational science with immediate or potential future applications within areas of relevance to NNF’s strategy.
The project may include up to 5 collaborators. The proposed research project should demonstrate synergistic collaboration between different research groups, typically from different institutions/departments and different scientific disciplines.
Funding: The maximal size of the grant scales with the size of the collaborative consortia. Maximally DKK 14M ($2.2M) for 2 partners, DKK 20M ($3.1M)for 3 partners, DKK 28M ($4.4M)) for 4 partners, and DKK 40M ($6.3M) for 5 partners.
https://novonordiskfonden.dk/en/grant/data-science-collaborative-research-programme-2026/
American Chemical Society (ACS): ‘New Directions’ grants in the petroleum field
Supports new research directions in the petroleum field. Fundamental research is required as opposed to applied research or methods development.
ND grants are to be used to illustrate proof of concept/feasibility.
Pre-registration is required for new applicants.
Funding: $125K for 2 years.
Please contact research authority If planning to submit- nonprofit and no overhead
https://www.acs.org/funding/grants/petroleum-research-fund/programs/new-directions-grants.html
The Mark Foundation: Early Detection Award – Competitive LOI’s
To encourage innovation in research that enables the detection of the deadliest cancers at earlier stages when they can be intercepted or effectively treated, the American Association for Cancer Research (AACR), the Lustgarten Foundation, and The Mark Foundation for Cancer Research announce this Request for Proposals for projects focused on accelerating the development of effective new approaches to the early detection of cancer.
Funding: $2M for 2 years
https://themarkfoundation.org/early-detection-award/
Russell Sage Foundation (Core Program): Social Science research for the improvement of social and living conditions in the United States (LOI)
For the upcoming round, RSF will accept letters of inquiry (LOIs) under its core programs for:
- Future of Work;
- Social, Political, and Economic Inequality.
Eligibility: Core research grants have no restrictions on nationality or institution location BUT, projects must focus on the social and living conditions in U.S. In exceptional cases, RSF may consider comparative projects or projects analyzing data collected outside the U.S., if the researcher can demonstrate that the data needed for the project is not available, nor obtainable, in the U.S., and that the analysis has strong relevance to improving social and living conditions in the United States.
Funding: up to $200K for 2 years.
www.russellsage.org/apply/grants / www.russellsage.org/research/priorities / www.russellsage.org/apply/application-deadlines
Schmidt Sciences: Humanities and Artificial Intelligence Virtual Institute (HAVI)
Aimed at fostering research in the digital humanities with a particular focus on artificial intelligence. Ideal projects will have co-PIs with expertise from both the humanities and AI and will address research questions from both domains. Expects humanities scholars to play integral roles in AI development, while AI researchers gain deeper understanding of data, models, and problem spaces from humanistic perspectives.
Funding: $100K – $299,999 (Level I for new research projects without an established record of past success), $300K-$800K (Level II, scaling up and expanding mature projects).
https://schmidtsciences.smapply.io/prog/2026_humanities_and_artificial_intelligence_virtual_institute_havi_rfp/
Wellcome Trust: Genomics in Context Awards: collaborative research at the intersection of genomics, humanities, social sciences and bioethics
These awards will support transdisciplinary teams to catalyse research discoveries at the intersection of genomics, humanities, social sciences and bioethics. Funded projects will be given the time and resources to create new research agendas and explore innovative ways of working.
Each application must include one lead applicant and 1-4 co applicants.
Funding: Up to £500,000 per project for 12-24 months
https://wellcome.org/research-funding/schemes/genomics-in-context-awards#who-can-apply-aa30
The Morton Cure Paralysis Fund (MCPF): Research Grants
Funds activities that hold promise of identifying therapies (cures) for paralysis in humans. It has particular focus on placing projects in the research pipeline, that is, enabling scientists to develop the proof concept data necessary to apply for larger NIH grants. The development of effective therapies for chronic injury is a high priority for the organization. Basic research will be supported if it has clear potential to accelerate progress at the applied end of the continuum and/or if it reflects innovative research or a ‘change of direction’.
Funding: $5K to $75K for 1 year (second year considered, no overhead)
https://mcpf.org/new-investigator-grant-application/
https://mcpf.org/wp-content/uploads/2025/02/MCPF-Research-Guidelines-1.doc
The Michael J. Fox foundation: Parkinson’s Disease Therapeutics Pipeline Program
Applicants may submit a pre-proposal application at any time. Pre-proposals will be reviewed by MJFF within three weeks of submission. Applicants whose pre-proposal is selected for further consideration will be invited to submit a full proposal through one of the four review cycles.
This program seeks to advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease (PD). The program is set up to benefit therapeutics with clear potential to prevent, stop, or delay disease progression or to reduce the burden of daily symptoms.
The Therapeutics Pipeline Program is only open to industry and industry-academia collaborations.
Funding: Award amounts for this program may range from $250,000 for smaller, targeted programs to upwards of $2M for larger, multi-stage preclinical and/or clinical programs
Duration: 1-2 years for pre-clinical programs, 2-3 years for clinical programs
DOD/US Army Research Office: Broad Agency Announcement (BAA) for LPS Qubit Collaboratory (LQC)
(Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period from the BAA release date to the BAA closing date)
The Lab for Quantum Computing (LQC) has three main goals (please see BAA for more details):
- Advance fundamental research and technologies for quantum computing and related applications, particularly focusing on qubit development.
- Foster strong partnerships to address challenging long-term issues in quantum information science and technology.
- Develop the future quantum workforce by offering research experiences in government and with LQC partners.
LQC’s success will be marked by substantial progress in solving complex, long-term research problems in quantum information science and technology, which will propel the field forward. These challenges include improving device performance, exploring alternative qubit physics and gate types, and enhancing materials to boost qubit gate fidelity.
Funding: Incubator proposals are expected to be 1-3 years in duration and not exceed $500K/year. Longer proposals may be considered due to scheduling requirements of fabrication and experiments.
Breakthrough T1D (formerly JDRF): Project Concepts – Competitive LOI’s
A semi-annual submission for Strategic Research Agreement Letters of Intent that address Breakthrough T1D’s current Research Strategy.
https://www.breakthrought1d.org/explore-research/research-strategy/
https://www.breakthrought1d.org/explore-research/funding-opportunities/
Novo Nordisk Foundation: Infectious Diseases Catalyst Grants
* The main applicant must be anchored and have their primary employment and research group at a university, hospital, or other non-profit research institution in Denmark. It is possible to include one international co-applicant.
To provide catalytic funding for exploratory research projects within the thematic research areas pathogenic fungi, novel antimicrobial resistance (AMR) tools, and harnessing innate immunity. Within these thematic areas, the aim is to stimulate Danish research, strengthen international collaborations, and to initiate innovative research projects with exceptional potential for future direct impact on global challenges.
Funding: up to DKK 6.5M ($1M) for up to 3 years.
https://novonordiskfonden.dk/en/grant/infectious-diseases-catalyst-grants-2025/
Novo Nordisk Foundation: Steno Collaborative Grants
* The main applicant must be anchored at a Steno Diabetes Center or a Steno Partner institution. A university, hospital, municipality or other non-profit research or diabetes care institution in Denmark or abroad is also eligible as a co-applicant.
With this call, the Novo Nordisk Foundation wishes to strengthen the collaboration between the Steno Diabetes Centers and the research environments related to the Centers. The foundation will support research projects with a unifying and collaborative mission to develop knowledge, to exchange experience across the research institutions and to facilitate synergy between the research environments around the Steno Diabetes Centers.
Funding: between DKK 300K ($47K)- DKK 10M ($1.5M) for 1-5 years.
https://novonordiskfonden.dk/en/grant/steno-collaborative-grants/
The Michael J. Fox foundation: Parkinson’s Disease Therapeutics Pipeline Program
Applicants may submit a pre-proposal application at any time. Pre-proposals will be reviewed by MJFF within three weeks of submission. Applicants whose pre-proposal is selected for further consideration will be invited to submit a full proposal through one of the four review cycles.
This program seeks to advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease (PD). The program is set up to benefit therapeutics with clear potential to prevent, stop, or delay disease progression or to reduce the burden of daily symptoms.
The Therapeutics Pipeline Program is only open to industry and industry-academia collaborations.
Funding: Award amounts for this program may range from $250,000 for smaller, targeted programs to upwards of $2M for larger, multi-stage preclinical and/or clinical programs
Duration: 1-2 years for pre-clinical programs, 2-3 years for clinical programs
Russell Sage Foundation (Core Program): Social Science research for the improvement of social and living conditions in the United States (LOI)
For the upcoming round, RSF will accept letters of inquiry (LOIs) under its core programs for:
- Behavioral Science and Decision Making in Context;
- Immigration and Immigrant Integration;
- Race, Ethnicity and Immigration;
Eligibility: Core research grants have no restrictions on nationality or institution location BUT, projects must focus on the social and living conditions in U.S. In exceptional cases, RSF may consider comparative projects or projects analyzing data collected outside the U.S., if the researcher can demonstrate that the data needed for the project is not available, nor obtainable, in the U.S., and that the analysis has strong relevance to improving social and living conditions in the United States.
Funding: up to $200K for 2 years.
www.russellsage.org/apply/grants / www.russellsage.org/research/priorities / www.russellsage.org/apply/application-deadlines
Parkinson’s UK: Drug Accelerator Awards – preproposals
These awards will help pioneer and accelerate novel drug development for the treatment of Parkinson’s, providing researchers the opportunity to generate the essential data and help bridge the gaps needed to get their projects/compounds ready to enter full scale drug discovery with an industry partner or the Parkinson’s Virtual Biotech.
Looking for projects that will have a clear focus on translational drug development to make a difference to those affected by Parkinson’s.
Funding: There is no minimum award amount and the maximum award amount is £150,000.
For projects involving in vivo work, an award amount of up to £200,000 will be considered.
Lead PI must be UK based
https://www.parkinsons.org.uk/research/drug-accelerator-awards
The Morton Cure Paralysis Fund (MCPF): Research Grants
Funds activities that hold promise of identifying therapies (cures) for paralysis in humans. It has particular focus on placing projects in the research pipeline, that is, enabling scientists to develop the proof concept data necessary to apply for larger NIH grants. The development of effective therapies for chronic injury is a high priority for the organization. Basic research will be supported if it has clear potential to accelerate progress at the applied end of the continuum and/or if it reflects innovative research or a ‘change of direction’.
Funding: $5K to $75K for 1 year (second year considered, no overhead)
https://mcpf.org/new-investigator-grant-application/
https://mcpf.org/wp-content/uploads/2025/02/MCPF-Research-Guidelines-1.doc
American Chemical Society (ACS): ‘New Directions’ grants in the petroleum field
Supports new research directions in the petroleum field. Fundamental research is required as opposed to applied research or methods development.
ND grants are to be used to illustrate proof of concept/feasibility.
Pre-registration is required for new applicants.
Funding: $125K for 2 years.
Please contact research authority If planning to submit- nonprofit and no overhead
https://www.acs.org/funding/grants/petroleum-research-fund/programs/new-directions-grants.html
US Army Medical Research and Development Command: Broad Agency Announcement (BAA) for Extramural Medical Research
(Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period from the BAA release date to the BAA closing date)
Research Areas of Interest (please see BAA for more details)
- Military Infectious Diseases Research Program
Research and development of solutions for the prevention, treatment, and diagnosis of infectious diseases
- Combat Casualty Care Research Program
- technologies to stop blood loss, resuscitate the casualty, and limit the immediate, short-,and long-term deleterious consequences of severe hemorrhage:
B technologies to diagnose and to limit the immediate, short-, and long-term impairments that follow TBI
- Technologies to diagnose and reduce acute secondary organ damage
- The delivery of care during transport
- Clinical practice of novel/optimized treatments for severe burn injuries
- Pain Management
- Regenerative Medicine
- Autonomous Care and Evacuation / Medical Assist Support Technologies (MAST)
- Medical Countermeasures (MCMs) for Acute Radiation Exposure
- Combined Injury
III. Military Operational Medicine Research Program
- Injury Prevention and Treatment
- Psychological Health and Resilience
- Physiological Health and Performance
- Environmental Health and Protection
- Medical Biological Defense Research Program
- Viral, Toxin, and Bacterial Studies
- Drug Development
- Identification, Diagnosis, and other Medical Interventions
- Biosurveillance(BSV)
- Medical Chemical Defense Research Program
Funding: not specified. Duration: 4 years.
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=549112
US Department of Health & Human Services/Office of Biomedical Advanced Research and Development Authority (BARDA): Division of Research, Innovation & Ventures (DRIVe)- (Abstracts)
(Abstracts may be submitted at any time until the closing date)
AOI #20 DRIVe Forward
Aims to develop products, capabilities, and technologies to detect threats, improve patient care, including ancillary supplies and resources, as well as novel approaches to develop, clinically validate, and deploy/distribute MCMs rapidly and agnostically.
Especially interested in proposals that aim to address one or more of the following topics:
- Microbiome-based therapies
- Resilience to infection
- Next-generation vaccines
- Next-generation therapeutic antibodies
- Artificial blood products
- Extremely mobile viral diagnostic platforms for use in extremely remote settings
- Non-pharmacological approaches for enhanced immunity
Funding: up to $750K.
https://drive.hhs.gov/partner.html
https://drive.hhs.gov/files/ezbaa_files/DRIVe_EZ-BAA_Special_Instructions_01.pdf
DOD/ DEVCOM Army Rsearch Laboratory (ARL): Broad Agency Announcement (BAA) Foundational Research (W911NF-23-S-0001)
(Accepting applications on a rolling basis until the deadline)
Research Areas of Interest (please see BAA for more details)
DEVCOM ARL executes intramural and extramural research organized by eleven competencies
that provide the Army with foundational expertise and specialized capabilities grounded in
scientific excellence and driven by unique Army challenges.
The eleven DEVCOM ARL competencies are:
- Biological and Biotechnology Sciences
- Electromagnetic Spectrum Sciences
- Energy Sciences
- Humans in Complex Systems
- Mechanical Sciences
- Military Information Sciences
- Network, Cyber, and Computational Sciences
- Photonics, Electronics, and Quantum Sciences
- Sciences of Extreme Materials
- Terminal Effects
- Weapons Sciences
https://www.grants.gov/search-results-detail/344592
For the full list of opportunities under this BAA:
https://cftste.experience.crmforce.mil/arlext/s/arl-opportunities
DOD/ United States Special Operations Command (USSOCOM): Broad Agency Announcement (BAA) Extramural Biomedical and Human Performance Research and Development (HT9425-23-S-SOC1)
(Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period from the BAA release date to the BAA closing date)
Research Areas of Interest (please see BAA for more details)
- Damage Control Resuscitation
- Prolonged Field Care (PFC)
- Portable Lab Assays and Diagnostics
- Force Health Protection and Environmental Medicine
- Brain Health
- Immune Response
- Chronic Pain
- Automation of Systematic Reviews and Metanalysis
- Medical Simulation and Training Technologies
- Human Performance Optimization
- Canine Medicine and Performance
Most projects are anticipated to have a total cost at or below $1,500,000 (including indirect costs). Projects that have a total cost higher than $1,500,000 (including Indirect costs) with outstanding scientific merit that meet a critical need may be accepted; however the total cost of these projects are not to exceed $5,000,000.00 (including Indirect costs).
Duration: up to 5 years.
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=549113
